The pulmonary function pattern marked A in chronic beryllium disease (CBD) is a restrictive pattern with reduced TLC and markedly reduced DLCO. The case demonstrates the classic CBD physiology: proportional reduction in all lung volumes (TLC 62% predicted, VC 60% predicted, FRC 66% predicted, RV 72% predicted) with a preserved FEV1/FVC ratio (0.82), indicating no airway obstruction. The miniaturized flow-volume loop with preserved peak expiratory flow and sharp descending limb is pathognomonic for restriction. Most critically, DLCO is markedly reduced at 40% predicted—reflecting the alveolar-capillary inflammation and granulomatous infiltration characteristic of CBD. This pattern is indistinguishable from sarcoidosis on PFT alone and requires occupational history and positive BeLPT for diagnosis (Mayer AS, Hamzeh N, Maier LA. Semin Respir Crit Care Med. 2014;35(3):316-329).
Mayer AS, Hamzeh N, Maier LA. Sarcoidosis and chronic beryllium disease: similarities and differences. Semin Respir Crit Care Med. 2014;35(3):316-329.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →